Janus Kinase Inhibitors for the Treatment of Pediatric Morphea: A Systematic Review
Pediatric Dermatology · 2026-05 · 43 (3) · 654-656
DOI: 10.1111/pde.70090 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pediatric Dermatology, online erschienen am 18.11.2025. Verfasst von Alexa Moschella und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Scleroderma, Localized, Janus Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Morphea, also known as localized scleroderma (LoS), is an inflammatory, fibrosing dermatologic disorder of the skin and underlying tissues with associated comorbidities including joint contractures, limb‐length discrepancies, and inflammatory arthropathy occurring more commonly in children. While standardized consensus treatment plans for pediatric LoS have been developed by the Childhood Arthritis and Rheumatology Research Alliance, the use of Janus kinase (JAK) inhibitors in the treatment of pediatric LoS has recently been reported. This review, which systematically summarizes the published literature on the use of oral and topical JAK inhibitors for pediatric LoS, identified nine studies (involving 16 patients across all studies) that met inclusion criteria with improvement following JAK inhibitor initiation reported in 94% ( n = 15) of cases. Overall, these findings demonstrate that JAK inhibitors may offer a promising alternative to treat pediatric morphea; however, more robust studies are required to evaluate the efficacy of JAK inhibitors in treating pediatric LoS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Division of Dermatology, The Ottawa Hospital, Ottawa, Ontario, Canada.
- Division of Dermatology and Rheumatology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
ORCID-Profile: Alexa Moschella, Celina DeBiasio, Carmen Liy-Wong
Zitieren
APA
Moschella, A., DeBiasio, C., & Liy-Wong, C. (2026). Janus Kinase Inhibitors for the Treatment of Pediatric Morphea: A Systematic Review. Pediatric Dermatology, 43(3), 654-656. https://doi.org/10.1111/pde.70090
Vancouver
Moschella A, DeBiasio C, Liy-Wong C. Janus Kinase Inhibitors for the Treatment of Pediatric Morphea: A Systematic Review. Pediatric Dermatology. 2026;43(3):654-656. doi:10.1111/pde.70090
BibTeX
@article{Moschella2026,
author = {Moschella, Alexa and DeBiasio, Celina and Liy-Wong, Carmen},
title = {Janus Kinase Inhibitors for the Treatment of Pediatric Morphea: A Systematic Review},
journal = {Pediatric Dermatology},
year = {2026},
volume = {43},
number = {3},
pages = {654--656},
doi = {10.1111/pde.70090}
}
EUVIMED